BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2024 7:07:39 AM | Browse: 75 | Download: 184
 |
Received |
|
2024-06-05 04:49 |
 |
Peer-Review Started |
|
2024-06-05 04:49 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-06-26 06:06 |
 |
Revised |
|
2024-07-09 14:17 |
 |
Second Decision |
|
2024-07-17 02:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-07-17 09:44 |
 |
Articles in Press |
|
2024-07-17 09:44 |
 |
Publication Fee Transferred |
|
2024-07-18 12:52 |
 |
Edit the Manuscript by Language Editor |
|
2024-08-01 01:35 |
 |
Typeset the Manuscript |
|
2024-08-05 00:27 |
 |
Publish the Manuscript Online |
|
2024-08-13 07:07 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Urology & Nephrology |
Manuscript Type |
Case Report |
Article Title |
Toripalimab in combination with chemotherapy effectively suppresses local recurrence and metastatic sarcomatoid renal cell carcinoma: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ming-Zhu Gao, Nian-Fei Wang, Jin-You Wang, Li Ma and Yu-Cai Yang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
The Health Research Program of Anhui Province, China |
No. AHWJ2022b048 |
The Research Foundation of Anhui Medical University, China |
No. 2021xkj164 |
The Clinical Scientific Research Cultivation Project of the Second Affiliated Hospital of Anhui Medical University, China |
No. 2021LCZD04 |
|
Corresponding Author |
Jin-You Wang, MD, Surgeon, Surgical Oncologist, Teacher, Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Furong Road, Hefei 230601, Anhui Province, China. jinyouwang@126.com |
Key Words |
Renal cell carcinoma; Sarcomatoid dedifferentiation; Immune checkpoint inhibitor; Chemotherapy; Case report |
Core Tip |
Sarcomatoid renal cell carcinoma (SRCC) is a highly aggressive and uncommon malignant tumor of the kidney, which is associated with a rapid clinical course and unfavorable prognosis compared to conventional renal cell carcinoma. Traditional chemotherapy and targeted therapies have limited efficacy against SRCC. We present a rare case of recurrent and metastatic SRCC that achieved excellent outcomes with the combination of immunotherapy and chemotherapy. This study sheds new light on diagnostic and therapeutic approaches of SRCC. |
Publish Date |
2024-08-13 07:07 |
Citation |
<p>Gao MZ, Wang NF, Wang JY, Ma L, Yang YC. Toripalimab in combination with chemotherapy effectively suppresses local recurrence and metastatic sarcomatoid renal cell carcinoma: A case report. <i>World J Clin Cases</i> 2024; 12(28): 6230-6236</p> |
URL |
https://www.wjgnet.com/2307-8960/full/v12/i28/6230.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v12.i28.6230 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345